Protein Description

Gene Symbol EGR1
Entrez ID 1958
Uniprot ID P18146
Description early growth response 1
Chromosomal Location chr5: 138,465,490-138,469,315
Ontology GO ID GO Term Definition Evidence

BP

GO:0000122

negative regulation of transcription from RNA polymerase II promoter

Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IEA

BP

GO:0001666

response to hypoxia

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.

ISS

BP

GO:0002931

response to ischemia

Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply.

ISS

BP

GO:0006366

transcription from RNA polymerase II promoter

The synthesis of RNA from a DNA template by RNA polymerase II, originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).

IDA

BP

GO:0009749

response to glucose

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.

IEA

BP

GO:0030217

T cell differentiation

The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.

IEA

BP

GO:0030509

BMP signaling pathway

A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IEA

BP

GO:0032868

response to insulin

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.

IEA

BP

GO:0033233

regulation of protein sumoylation

Any process that modulates the frequency, rate or extent of the addition of SUMO groups to a protein.

IDA

BP

GO:0035914

skeletal muscle cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of a skeletal muscle cell, a somatic cell located in skeletal muscle.

IEA

BP

GO:0042981

regulation of apoptotic process

Any process that modulates the occurrence or rate of cell death by apoptotic process.

IEA

BP

GO:0044849

estrous cycle

A type of ovulation cycle, which occurs in most mammalian therian females, where the endometrium is resorbed if pregnancy does not occur.

ISS

BP

GO:0045080

positive regulation of chemokine biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of chemokines.

ISS

BP

GO:0045893

positive regulation of transcription, DNA-templated

Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.

IDA

BP

GO:0045944

positive regulation of transcription from RNA polymerase II promoter

Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.

IDA|IGI|IMP

BP

GO:0046886

positive regulation of hormone biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hormones.

ISS

BP

GO:0050725

positive regulation of interleukin-1 beta biosynthetic process

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-1 beta.

ISS

BP

GO:0060337

type I interferon signaling pathway

A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

TAS

BP

GO:0061418

regulation of transcription from RNA polymerase II promoter in response to hypoxia

Any process that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter as a result of a hypoxia stimulus.

IEA

BP

GO:0070498

interleukin-1-mediated signaling pathway

A series of molecular signals initiated by the binding of interleukin-1 to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.

IMP

BP

GO:0071480

cellular response to gamma radiation

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.

IEA

BP

GO:0071504

cellular response to heparin

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heparin stimulus.

ISS

BP

GO:0071506

cellular response to mycophenolic acid

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mycophenolic acid stimulus.

ISS

BP

GO:0072110

glomerular mesangial cell proliferation

The multiplication or reproduction of glomerular mesangial cells, resulting in the expansion of the population.

ISS

BP

GO:0072303

positive regulation of glomerular metanephric mesangial cell proliferation

Any process that increases the frequency, rate or extent of metanephric glomerular mesangial cell proliferation.

ISS

BP

GO:0090090

negative regulation of canonical Wnt signaling pathway

Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.

IEA

BP

GO:0098759

cellular response to interleukin-8

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-8 stimulus.

IDA

BP

GO:2000182

regulation of progesterone biosynthetic process

Any process that modulates the frequency, rate or extent of progesterone biosynthetic process.

ISS

CC

GO:0005634

nucleus

A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

IDA|ISS

CC

GO:0005654

nucleoplasm

That part of the nuclear content other than the chromosomes or the nucleolus.

IDA|TAS

CC

GO:0005737

cytoplasm

All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

IDA|ISS

MF

GO:0000976

transcription regulatory region sequence-specific DNA binding

Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon.

IDA

MF

GO:0000977

RNA polymerase II regulatory region sequence-specific DNA binding

Interacting selectively and non-covalently with a specific sequence of DNA that is part of a regulatory region that controls the transcription of a gene or cistron by RNA polymerase II.

IDA

MF

GO:0001077

transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding

Interacting selectively and non-covalently with a sequence of DNA that is in cis with and relatively close to a core promoter for RNA polymerase II (RNAP II) in order to activate or increase the frequency, rate or extent of transcription from the RNAP II promoter.

IEA

MF

GO:0003677

DNA binding

Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

IDA

MF

GO:0003700

transcription factor activity, sequence-specific DNA binding

Interacting selectively and non-covalently with a specific DNA sequence in order to modulate transcription. The transcription factor may or may not also interact selectively with a protein or macromolecular complex.

IDA

MF

GO:0005515

protein binding

Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).

IPI

MF

GO:0008270

zinc ion binding

Interacting selectively and non-covalently with zinc (Zn) ions.

IDA

MF

GO:0010385

double-stranded methylated DNA binding

Interacting selectively and non-covalently with double-stranded methylated DNA. Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks.

IDA

MF

GO:0035035

histone acetyltransferase binding

Interacting selectively and non-covalently with the enzyme histone acetyltransferase.

IPI

MF

GO:0043565

sequence-specific DNA binding

Interacting selectively and non-covalently with DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA e.g. promotor binding or rDNA binding.

IDA

MF

GO:0044729

hemi-methylated DNA-binding

Interacting selectively and non-covalently with double-stranded hemi-methylated DNA at replication foci (one strand methylated, while the other strand is unmethylated). Methylation of cytosine or adenine in DNA is an important mechanism for establishing stable heritable epigenetic marks.

IDA

MF

GO:1990841

promoter-specific chromatin binding

Interacting selectively and non-covalently with a section of chromatin that is associated with gene promoter sequences of DNA.

IDA

Domain ID Description

IPR013083

Zinc finger, RING/FYVE/PHD-type

IPR013087

Zinc finger C2H2-type

IPR021839

Protein of unknown function DUF3432

IPR021849

Protein of unknown function DUF3446

Pathway ID Pathway Term Pathway Source

hsa04371

Apelin signaling pathway

KEGG

hsa04933

AGE-RAGE signaling pathway in diabetic complications

KEGG

hsa05020

Prion diseases

KEGG

hsa05166

HTLV-I infection

KEGG

WP2431

Spinal Cord Injury

WikiPathways

WP734

Serotonin Receptor 4/6/7 and NR3C Signaling

WikiPathways

WP706

Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways

WikiPathways

WP2884

NRF2 pathway

WikiPathways

WP34

Ovarian Infertility Genes

WikiPathways

WP481

Insulin Signaling

WikiPathways

WP2374

Oncostatin M Signaling Pathway

WikiPathways

WP3527

Preimplantation Embryo

WikiPathways

WP3594

Circadian rythm related genes

WikiPathways

WP2032

Human Thyroid Stimulating Hormone (TSH) signaling pathway

WikiPathways

WP2380

Brain-Derived Neurotrophic Factor (BDNF) signaling pathway

WikiPathways

WP3888

VEGFA-VEGFR2 Signaling Pathway

WikiPathways

h_cdk5Pathway

Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway

BioCarta

UMLS CUI UMLS Term

C0003130

Anoxia

C0007786

Brain Ischemia

C0008370

Cholestasis

C0008372

Intrahepatic Cholestasis

C0020295

Hydronephrosis

C0021368

Inflammation

C0022116

Ischemia

C0025500

Mesothelioma

C0033578

Prostatic Neoplasms

C0035126

Reperfusion Injury

C0236736

Cocaine-Related Disorders

C3495559

Juvenile Arthritis

Tissue Cell Type

adrenal gland

glandular cells

ovary

ovarian stroma cells

smooth muscle

smooth muscle cells

thyroid gland

glandular cells

tonsil

non-germinal center cells

urinary bladder

urothelial cells

vagina

squamous epithelial cells

No databases found.

Pubmed ID Author Year Title

15308691

Jansen et al.

2004

Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients

17062763

Corton et al.

2007

Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome

22617121

Ouandaogo et al.

2012

Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation

Gene Symbol Entrez ID Uniprot ID Score

MDM2

4193

Q00987

0.63

PTEN

5728

P60484

0.63

SRA1

10011

Q9HD15

0.63

CDKN2A

1029

Q8N726

0.68

CDKN2A

1029

P42771

0.70

FOSL2

2355

P15408

0.72

JUNB

3726

P17275

0.72

JUND

3727

P17535

0.72

MAGEB2

4113

O15479

0.72

PSMD2

5708

Q13200

0.72

MED6

10001

O75586

0.72

POP1

10940

Q99575

0.72

DNAJC8

22826

O75937

0.72

PHIP

55023

Q8WWQ0

0.72

ARID2

196528

Q68CP9

0.72

SP1

6667

P08047

0.84

NFATC2

4773

Q13469

0.52

CSNK2A1

1457

P68400

0.55

JUN

3725

P05412

0.55

WT1

7490

P19544

0.56

CTNNB1

1499

P35222

0.63

IL1B

3553

P01584

0.63

PFDN5

5204

Q99471

0.63

SREBF2

6721

Q12772

0.63

TCF4

6925

P15884

0.63

VDR

7421

P11473

0.63

LEF1

51176

Q9UJU2

0.63

TBX2

6909

Q13207

0.65

NAB2

4665

Q15742

0.67

ERBB3

2065

P21860

0.72

SNAI1

6615

O95863

0.73

NFATC1

4772

O95644

0.75

PITX1

5307

P78337

0.75

RELA

5970

Q04206

0.75

NAB1

4664

Q13506

0.78

CREBBP

1387

Q92793

0.79

SUMO1

7341

P63165

0.82

PSMA3

5684

P25788

0.87

CEBPB

1051

P17676

0.88

EP300

2033

Q09472

0.90

TP53

7157

P04637

0.90